Fundamental Valuation Report Nomad Foods(NOMD:NYS) Consumer Defensive:Packaged Foods This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date23.70 (EUR) / $28.74 (USD) 05/07/2021 Weighted Valuation24.38 (EUR) / $29.57 (USD) Use …
Nomad Foods (NOMD:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Sunnova Energy Intl(NOVA:NYS) Technology:Solar This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.82 (USD) 05/07/2021 Weighted Valuation$31.57 (USD) Overall RatingFairly valued to slightly Overvalued by 0.8% Valuation Models …
Sunnova Energy Intl (NOVA:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report LSB Industries(LXU:NYS) Basic Materials:Chemicals This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.88 (USD) 05/06/2021 Weighted Valuation$5.99 (USD) Overall RatingFairly valued to slightly Undervalued by 1.9% Valuation Models …
LSB Industries (LXU:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report LyondellBasell Industries(LYB:NYS) Basic Materials:Specialty Chemicals This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$114.13 (USD) 05/06/2021 Weighted Valuation$118.96 (USD) Overall RatingFairly valued to slightly Undervalued by 4.2% Valuation …
LyondellBasell Industries (LYB:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Mattel(MAT:NAS) Consumer Cyclical:Leisure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$22.29 (USD) 05/06/2021 Weighted Valuation$22.00 (USD) Overall RatingFairly valued to slightly Overvalued by 1.3% Valuation Models Multiples: $19.62 …
Mattel (MAT:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report MediWound(MDWD:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$3.90 (USD) 05/06/2021 Weighted Valuation$3.95 (USD) Overall RatingFairly valued to slightly Undervalued by 1.3% Valuation Models Comparables: $3.95 (USD) …
MediWound (MDWD:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Macrogenics(MGNX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.86 (USD) 05/06/2021 Weighted Valuation$31.57 (USD) Overall RatingFairly valued to slightly Overvalued by 0.9% Valuation Models Comparables: $24.70 (USD) …
Macrogenics (MGNX:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Brigham Minerals(MNRL:NYS) Energy:Oil & Gas E&P This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.44 (USD) 05/07/2021 Weighted Valuation$18.35 (USD) Overall RatingFairly valued to slightly Overvalued by 0.5% …
Brigham Minerals (MNRL:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Merck & Co(MRK:NYS) Healthcare:Drug Manufacturers – General This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$78.41 (USD) 05/07/2021 Weighted Valuation$79.39 (USD) Overall RatingFairly valued to slightly Undervalued by …
Merck & Co (MRK:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Mirati Therapeutics(MRTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$144.00 (USD) 05/07/2021 Weighted Valuation$148.78 (USD) Overall RatingFairly valued to slightly Undervalued by 3.3% Valuation Models Comparables: $165.51 …
Mirati Therapeutics (MRTX:NAS) Fundamental Valuation Report Read more »
Read More